| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.31 | 0.09 |